๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2857726 F NJ 09/10/2025 HEP
 DYNAVAX TECHNOLOGIES CORPORATION
Wrong product administered Wrong product administered
Received their First Dose of HEPLISAV-B on July 21st 2025 Then Got ENGERIX-B instead of HEPLISAV-B 2... Received their First Dose of HEPLISAV-B on July 21st 2025 Then Got ENGERIX-B instead of HEPLISAV-B 21-AUG-2025; Initial report received on 22-Aug-2025. A pharmacist in the reported that a patient received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization on 21-Jul-2025 and received ENGERIX-B as the second dose on 21-Aug-2025. No medical history or concomitant medications were reported. On 21-Jul-2025, the patient received dose 1 of a hepatitis B vaccine HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available). On 21-Aug-2025, 32 days after receiving HEPLISAV-B, the patient received dose 2 of a hepatitis B vaccine ENGERIX-B (lot number, expiration date, route, and site not available). No additional information was reported. Company Comment:; Sender's Comments: The company assessed the event as non-serious. More
2857727 F 09/10/2025 HEP
 DYNAVAX TECHNOLOGIES CORPORATION
Extra dose administered Extra dose administered
Received HEPLISAV-B then Received Another Hepatitis B Shot; Initial report received on 25-Aug-2025. ... Received HEPLISAV-B then Received Another Hepatitis B Shot; Initial report received on 25-Aug-2025. A consumer reported that she, a female patient, received HEPLISAV-B (hepatitis B vaccine) for the first dose of hepatitis B immunization, then received an unknown hepatitis B vaccine , and then received the second dose of HEPLISAV-B. No medical history or concomitant medications were reported. In Jul-2025, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On 18-Aug-2025, approximately one month after receiving HEPLISAV-B, the patient received an unknown hepatitis B vaccine (lot number, expiration date, route, and site not available). On 22-Aug-2025, approximately one month after receiving HEPLISAV-B and 4 days after receiving a dose of an unknown hepatitis B vaccine , the patient received dose 2 of HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available). The reporter declined to provide further information. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious. More
2857728 PA 09/10/2025 HEP
 DYNAVAX TECHNOLOGIES CORPORATION
Therapy non-responder Therapy non-responder
Had Complete ENGERIX-B Series and Complete HEPLISAV-B Series and is a Non-Responder to Hepatitis B V... Had Complete ENGERIX-B Series and Complete HEPLISAV-B Series and is a Non-Responder to Hepatitis B Vaccines; Initial report received on 25-Aug-2025. A nurse reported that a patient received the complete HEPLISAV-B (hepatitis B vaccine) series after receiving the complete ENGERIX-B for hepatitis B immunization but continued to be a non-responder to the hepatitis B vaccines. No medical history or concomitant medications were reported. On an unknown date, the patient completed the ENGERIX-B hepatitis B vaccine series (lot numbers, expiration dates, NDC numbers, route, and sites not available). On an unknown date, the patient received dose 1 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On an unknown date, the patient received dose 2 of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available)]. On an unknown date, after receiving the complete HEPLISAV-B series, the patient was noted to be a non-responder to the hepatitis B vaccines. No additional information was reported. Company Comment: The company assessed the event as non-serious. The event is not immunologically confirmed due to lack of information on dosing and serological marker.; Sender's Comments: The company assessed the event as non-serious. The event is not immunologically confirmed due to lack of information on dosing and serological marker. More
2857729 F TX 09/10/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Fatigue, Pyrexia Fatigue, Pyrexia
Fatigue; Low grade fever; This non-serious case was reported by a consumer via call center represent... Fatigue; Low grade fever; This non-serious case was reported by a consumer via call center representative and described the occurrence of fatigue in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Additional patient notes included prior vaccines She usually reacts to vaccines. She did not mention any specific examples but did mention she is due for a flu shot and a covid-19 shot.. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced fatigue (Verbatim: Fatigue) and low grade fever (Verbatim: Low grade fever). The outcome of the fatigue and low grade fever were resolved. It was unknown if the reporter considered the fatigue and low grade fever to be related to Shingrix. It was unknown if the company considered the fatigue and low grade fever to be related to Shingrix. Additional Information: GSK Receipt Date: 04-SEP-2025 The patient reported that she received Shingrix shot one a couple of months ago. She said with the first dose, she did feel pretty bad. She usually do kind of react to shots, it wasn't an allergic reaction or anything. She indicated that she did not report this to her doctor because she usually reacts to vaccines and did not think it was unusual. She read that side effects could be expected/typical. To elaborate on felt pretty bad, she said that it was mostly fatigue and maybe a low-grade fever the evening of the vaccine and maybe the next morning, but it was not high enough that she took her temperature. More
2857730 09/10/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
received first Shingrix shot in January; This non-serious case was reported by a consumer via call c... received first Shingrix shot in January; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix in Jan 2025). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: received first Shingrix shot in January). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 31-AUG-2025 The patient received first Shingrix shot in Jan 2025. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. More
2857731 F NJ 09/10/2025 HEPAB
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
never completed the series, now wants the third dose; This non-serious case was reported by a pharma... never completed the series, now wants the third dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 64-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (first dose of Twinrix in Sep 2022 (4F3YY expiry date 01 Jan 2023),) and Twinrix (second dose in Oct 2022). On an unknown date, the patient received the 3rd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: never completed the series, now wants the third dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-AUG-2025 Pharmacist called to report that patient got first dose of Twinrix in Sep 2022 and the second dose in Oct 2022 but never received the third dose. Now the patient wants the third dose. Till the time of reporting, the patient did not receive 3rd dose of Twinrix, which led to incomplete course of vaccination. More
2857732 22 F GA 09/10/2025 HEPAB
 GLAXOSMITHKLINE BIOLOGICALS
Inappropriate schedule of product administration Inappropriate schedule of product administration
received the first dose of Twinrix on 28 Feb 2025 and the second dose was given 01 Jun 2025; This no... received the first dose of Twinrix on 28 Feb 2025 and the second dose was given 01 Jun 2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 22-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received the first dose of Twinrix on 28 Feb 2025). On 01-JUN-2025, the patient received the 2nd dose of Twinrix. On 01-JUN-2025, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: received the first dose of Twinrix on 28 Feb 2025 and the second dose was given 01 Jun 2025). The outcome of the drug dose administration interval too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-AUG-2025 Pharmacist reported that a patient received the first dose of Twinrix on 28 Feb 2025 and the second dose was given 01 Jun 2025 which led to Drug dose administration interval too long. More
2857733 85 M 09/10/2025 COVID19-2
 MODERNA
 AS7140C
Immunodeficiency, White blood cell count Immunodeficiency, White blood cell count
unsure if his low immune system was pre-existing since they just started checking it a year ago; Thi... unsure if his low immune system was pre-existing since they just started checking it a year ago; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) in an 85-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. AS7140C and 065H22A) for COVID-19 prophylaxis. Concurrent medical conditions included Chronic leukemia and Breathing difficult. On 09-Sep-2022, the patient received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 20-Apr-2023, received seventh dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) (seriousness criterion medically significant). At the time of the report, IMMUNODEFICIENCY (unsure if his low immune system was pre-existing since they just started checking it a year ago) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: white count being so high (over 100,000) for 20 years. No concomitant medication was reported. Patient previously received Moderna vaccines on 01-Jan-2021 (lot#025L20A), 13-Jan-2021 (lot#025L20A), 10-Feb-2021 (lot#024M20A), 27-Sep-2021 (lot#041B21A) and 07-Feb-2022 (lot#007J21-2A). The patient received every Moderna vaccine that had come out since it was all started and the last one, he had was September 2024. The patient's doctor told him he needed to get another COVID vaccine this year. His health problems - breathing problems and chronic leukemia were pre-existing before receiving the COVID vaccines but was unsure if his low immune system was preexisting since they just started checking it a year ago. The patient needed infusions to bring his hemoglobin and IgG back up every 3 months. The patient's most of the problems were on account of his chronic leukemia and his white count being so high (over 100,000) for 20 years. The patient was never had any ill effects from any of his vaccines. This case was linked to MOD-2025-789056 (Patient Link).; Reporter's Comments: Patients Chronic leukemia is a strong confounder for the event immunodeficiency. The benefit-risk relationship of product is not affected by this report. More
2857734 F 09/10/2025 COVID19
 PFIZER\BIONTECH
Chills, Pyrexia Chills, Pyrexia
received 5 covid vaccine pretty much had the same side effects/experienced chills and slight fever; ... received 5 covid vaccine pretty much had the same side effects/experienced chills and slight fever; received 5 covid vaccine pretty much had the same side effects/experienced chills and slight fever; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A female patient received BNT162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), PYREXIA (non-serious), outcome "unknown" and all described as "received 5 covid vaccine pretty much had the same side effects/experienced chills and slight fever". Additional information: A consumer inquired whether the COMIRNATY (2025-2026 Formula) includes the new variant Stratus or the current variant. Another inquiry was made regarding the difference between the 2024-2025 and 2025-2026 formulations. Additionally, the consumer reported having received five prior COVID-19 vaccines with similar side effects, including chills and slight fever, and asked whether the current 2025-2026 formulation would cause the same side effects. In a separate inquiry, the consumer asked whether individuals aged 5 through 64 years who work as privacy are eligible to receive the vaccine or if a doctor's prescription is required. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500177331 same patient, different doses;US-PFIZER INC-202500177332 same patient, different doses;US-PFIZER INC-202500177333 same patient, different doses;US-PFIZER INC-202500177334 same patient, different doses; More
2857735 09/10/2025 COVID19
COVID19
 MODERNA
PFIZER\BIONTECH

Malaise, Pain, Pyrexia; Malaise, Pain, Pyrexia Malaise, Pain, Pyrexia; Malaise, Pain, Pyrexia
soreness; malaise; fever; This is a spontaneous report received from a Consumer or other non HCP. Ot... soreness; malaise; fever; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOD-2025-788935 (Moderna). A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), as dose 2 (initial pfizer dose), single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (SPIKEVAX), as dose 1, single for covid-19 immunisation. The patient's relevant medical history included: "immunosuppression NOS" (ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "recovered", described as "soreness"; MALAISE (non-serious), outcome "recovered"; PYREXIA (non-serious), outcome "recovered", described as "fever". Therapeutic measures were taken as a result of pain, malaise, pyrexia. Additional information: This spontaneous case was reported by a consumer and describes the occurrence of pain in extremity (experienced a little soreness in the arm), pain (soreness), malaise (malaise) and pyrexia (fever) in a patient who received Spikevax NOS (Spikevax NOS) for COVID-19 prophylaxis. Co-suspect product included non-company product Tozinameran (Pfizer BioNTech COVID-19 vaccine) for an unknown indication. Concurrent medical condition included immunosuppression NOS. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form and second dose of Tozinameran (Pfizer BioNTech COVID-19 vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced pain in extremity (experienced a little soreness in the arm), pain (soreness), malaise (malaise) and pyrexia (fever). The patient was treated with Acetylsalicylic acid (Aspirin) at an unspecified dose and frequency. At the time of the report, pain in extremity (experienced a little soreness in the arm), pain (soreness), malaise (malaise) and pyrexia (fever) had resolved. No concomitant medication was reported. The patient had less side effects with Moderna (COVID19) vaccine. The patient had both Moderna and Pfizer. With Pfizer, the patient had the second dose and everything else had been with Moderna. Also mentioned that had heard on the news that Moderna was more effective than Pfizer in the older population and that had less side effects with the Moderna vaccination. It was reported that with Moderna COVID19 vaccine, the patient experienced a little soreness in the arm for 2 days. In terms of the Pfizer vaccine, stated it had been a while either 2022 or 2023 when received the vaccine, but experienced a mild fever, soreness, malaise which aspirin cured after the 2nd day. The patient was at that age where immunity was marginal at best and that continued with wearing a mask in public places. It was unknown if the patient experienced any additional symptoms or events. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2857751 51 F AZ 09/10/2025 PNC20
 PFIZER\WYETH
 LX4484
Injection site erythema Injection site erythema
soon after vaccine patient had redness at injection site. By monday she called me at pharmacy. I s... soon after vaccine patient had redness at injection site. By monday she called me at pharmacy. I said common unless it starts to get bigger and is warm---then could be cellulitis concern. She showed me on Tuesday and I recommended to get seen for potential cellulitis and antibiotic. She filled it that evening 9/9/2025. More
2857752 54 M CA 09/10/2025 FLU3
 SANOFI PASTEUR
 U8830AA
Incorrect dose administered Incorrect dose administered
Pt received Flu zone High Dose rather than Standard Flu Zone by vaccine center staff: Pt received Flu zone High Dose rather than Standard Flu Zone by vaccine center staff:
2857753 37 M VA 09/10/2025 COVID19
 MODERNA
Mass, Swelling Mass, Swelling
Small lump at 0150 time. Diarrhea at time 0156 mild Small lump at 0150 time. Diarrhea at time 0156 mild
2857757 M 09/10/2025 RVX
 UNKNOWN MANUFACTURER
 UNK
Death Death
that poison killed my brother-in-law; This serious case was reported by a consumer via interactive d... that poison killed my brother-in-law; This serious case was reported by a consumer via interactive digital media and described the occurrence of death in a male patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced death (Verbatim: that poison killed my brother-in-law) (serious criteria death and GSK medically significant). The reported cause of death was death. The reporter considered the death to be related to RSV vaccine. The company considered the death to be unrelated to RSV vaccine. Additional Information: GSK receipt date: 04-SEP-2025 This case was reported by a patient's relative via interactive digital media. The reporter indicated that, this poison killed reporter's brother-in-law so reporter stated that do not tell them that it was safe and effective because it was not, also indicated that it was designed to take lives not save lives. This case is linked with US2025AMR114224, reported by same reporter.; Sender's Comments: A case of death, unknown time after receiving RSV vaccine, in a male patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received. US-GLAXOSMITHKLINE INC-US2025AMR114224:Case for father-in-law; Reported Cause(s) of Death: Death More
โœ“
2857758 F 09/10/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Expired product administered Expired product administered
administered a dose of Arexvy on Aug 22, 2025, that had expired July 2025; This non-serious case was... administered a dose of Arexvy on Aug 22, 2025, that had expired July 2025; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of expired vaccine used in a female patient who received RSVPreF3 adjuvanted (Arexvy) (expiry date 31-JUL-2025) for prophylaxis. On 22-AUG-2025, the patient received the 1st dose of Arexvy (unknown deltoid). On 22-AUG-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: administered a dose of Arexvy on Aug 22, 2025, that had expired July 2025). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 22-Aug-2025 No patient details provided by reporter. More
2857759 F TN 09/10/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Malaise, Vaccine positive rechallenge Malaise, Vaccine positive rechallenge
not feeling well for about 12 hours after each dose; This non-serious case was reported by a consume... not feeling well for about 12 hours after each dose; This non-serious case was reported by a consumer via sales rep and described the occurrence of feeling unwell in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of malaise (For tolerance of 1st dose refer case US2025AMR105885). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced feeling unwell (Verbatim: not feeling well for about 12 hours after each dose). Rechallenge with Shingrix was positive. The outcome of the feeling unwell was resolved (duration 12 hrs). It was unknown if the reporter considered the feeling unwell to be related to Shingrix. It was unknown if the company considered the feeling unwell to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR105885 Additional Information: GSK Receipt Date: 12-AUG-2025 The patient was approximately 55 years old. Patient got both doses of Shingrix as indicated. Patient not felt well for about 12 hours after each dose but recovered the next day.; Sender's Comments: US-GSK-US2025AMR105885:case for 1st dose More
2857760 12 F TX 09/10/2025 FLU3
 SANOFI PASTEUR
 U8527AA
Expired product administered, No adverse event Expired product administered, No adverse event
administered with an expired fluzone hd vaccine with no reported advesre event; administered with an... administered with an expired fluzone hd vaccine with no reported advesre event; administered with an expired fluzone hd vaccine with no reported advesre event; Initial information received on 05-Sep-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 12 years old female patient who was administered with an expired influenza USP trival A-B high dose subvirion vaccine [Fluzone High Dose] with no reported advesre event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 05-Sep-2025, the patient received 0.5 ml of dose 1 of an expired influenza USP trival A-B high dose subvirion vaccine Suspension for injection in pre-filled syringe with standard strength (expiry date- 30-JUN-2025 and lot U8527AA) once via intramuscular route in unknown administration site for Influenza immunization with no reported adverse event (expired product administered) (product administered to patient of inappropriate age) (latency- same day). Reportedly, List of concomitant vaccines: None. Treatment: No adverse event, no treatment Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2857761 1.17 F TX 09/10/2025 HIBV
 SANOFI PASTEUR
 UK166AB
No adverse event, Product preparation error No adverse event, Product preparation error
used sterile water as a diluent instead of the recommended saline with no reported adverse event; In... used sterile water as a diluent instead of the recommended saline with no reported adverse event; Initial information received on 05-Sep-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 14 months old female patient who received HIB (PRP/T) vaccine [ACT-HIB] and used sterile water as a diluent instead of the recommended saline with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria vaccine toxoid, Pertussis vaccine acellular, Tetanus vaccine toxoid (Daptacel); and Pneumococcal vaccine conj 7v (CRM197) (Prevnar) as both for Immunisation. On 05-Sep-2025, the patient received 0.5 ml of dose 4 of HIB (PRP/T) vaccine Powder and solvent for solution for injection with standard strength (expiry date- 30-SEP-2025 and lot UK166AB) once via intramuscular route in the left thigh for Immunization and used sterile water as a diluent instead of the recommended saline with no reported adverse event (product preparation error) (latency- same day). Reportedly, reporter was asking if the dose was invalid and needs to be repeated. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2857856 55 M NY 09/10/2025 COVID19
 MODERNA
Laboratory test normal, Skin hypopigmentation, Vitiligo Laboratory test normal, Skin hypopigmentation, Vitiligo
Within a few days of receiving my 2nd injection, I started to notice pigmentation changes in various... Within a few days of receiving my 2nd injection, I started to notice pigmentation changes in various locations on my body. I made an appointment for May 27, 2021 with a dermatologist who determined that the spots were Vitiligo, triggered by an overactive immune system. As time went on, the number white spots increased and grew larger. The doctor told me this was irreversible and permanent. I have checked the box on this form for "Disability or permanent damage" becauseI was told it is permanent, however I do not consider it a disability, although it is a cause for emotional discomfort because I have relatively dark skin. More
โœ“
2857857 44 M MA 09/10/2025 COVID19
 PFIZER\BIONTECH
 EW0172
Pyrexia Pyrexia
Persistent fever over 102๏ฟฝ for over three weeks Persistent fever over 102๏ฟฝ for over three weeks
2857858 1.5 F KY 09/10/2025 HEPA
HEPA
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Blood test normal, Dermatitis diaper, Exfoliative rash, Food intolerance, Inflam... Blood test normal, Dermatitis diaper, Exfoliative rash, Food intolerance, Inflammation; Perfume sensitivity, Rash, Rash erythematous, Rash papular, Rash pruritic More
constant diaper rash and sensitivity to foods, anything with a scent, and extreme inflammation. At ... constant diaper rash and sensitivity to foods, anything with a scent, and extreme inflammation. At one point a whole body rash which consisted of raised red bumps that were itchy and scaly. More
2857859 53 F MA 09/10/2025 TDAP
TDAP
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Limb mass, Muscle spasms, Myalgia, Skin irritation, Suture insertion; Tenderness Limb mass, Muscle spasms, Myalgia, Skin irritation, Suture insertion; Tenderness
I got a tdap last July 2024 after I had stitches put in and over a year later I still have a lump in... I got a tdap last July 2024 after I had stitches put in and over a year later I still have a lump in my arm that is sensitive to touch, nothing major or anything and its not black and blue or gaudy just a lump that sometimes clothes irritates it and sometimes the muscle there hurts and sometimes spasms as well, how do I get rid of it after over a year. More
2857860 12 F 09/10/2025 HPV9
 MERCK & CO. INC.
 Y013818
Fall, Head injury, Loss of consciousness, Pallor, Presyncope Fall, Head injury, Loss of consciousness, Pallor, Presyncope
Passed out fell hit head on floor Pale vasovagal response Passed out fell hit head on floor Pale vasovagal response
2857861 10 F 09/10/2025 HPV9
 MERCK & CO. INC.
 Y013818
Hyperhidrosis, Pallor, Presyncope Hyperhidrosis, Pallor, Presyncope
Patient had a vasovagal episode pale diaphoretic sugar given rest ice to neck Patient had a vasovagal episode pale diaphoretic sugar given rest ice to neck
2857862 14 M MD 09/10/2025 FLU3
 SEQIRUS, INC.
 406985
Hyperhidrosis, Loss of consciousness, Syncope Hyperhidrosis, Loss of consciousness, Syncope
The patient fainted in the chair right after receiving the flu vaccine. He regained consciousness i... The patient fainted in the chair right after receiving the flu vaccine. He regained consciousness immediately and was sweating profusely. He didn't know what happened, just suddenly blacked out. The patient sat in the chair for about 10-15 minutes drinking juice and felt better before walking around in the store and then going home. More
2857863 56 F GA 09/10/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 L227A
Chest pain, Pruritus Chest pain, Pruritus
Zoster (Shingrix) vaccine was given at 11:57 am and at 11:59 patient reported that she was itching o... Zoster (Shingrix) vaccine was given at 11:57 am and at 11:59 patient reported that she was itching on her arms, legs, and hair. Zyrtec 5mg (2 tablets for a total of 10mg) was given to patient in clinic and patient monitored for over 30 minutes. 911 was called at 12:18pm to further assess patient. 12:28pm patient reported having chest pain. EMS arrived at 12:32 and took over care. Patient declined going to the hospital for futher evaluation and walked out of clinic on her own. Patient declined further care at hospital because she reported that she is her mother's caregiver. More
2857864 71 M VA 09/10/2025 PNC21
 MERCK & CO. INC.
 Z004302
Asthenia, Blood test, Injection site cellulitis, Pyrexia Asthenia, Blood test, Injection site cellulitis, Pyrexia
Injection resulted to developing Cellulitis, treatment of antibiotics Cefuroxime Axetil 500mg prescr... Injection resulted to developing Cellulitis, treatment of antibiotics Cefuroxime Axetil 500mg prescribed by Dr (withheld). Patient still feeling weak, with low fever More
2857865 27 F NC 09/10/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 F4A7R
Cough, Erythema, Throat irritation, Visual impairment Cough, Erythema, Throat irritation, Visual impairment
Patient received flu vaccine at today's visit. Patient screened negative for past reactions to ... Patient received flu vaccine at today's visit. Patient screened negative for past reactions to flu vaccine prior to administration. After patient received flu vaccine, patient's face turned red and she began coughing, stating that she was seeing spots and her throat was scratchy. This RN informed Drs. who came to the bedside to assess patient. Patient's vitals were obtained and she was provided with water. Patient was asked to remain in room for about 20 minutes for observation and repeat vitals. Vital signs remained stable during this time, patient was provided with a snack, and symptoms and vitals were reassessed every 5 minutes. After observation period, patient stated that symptoms had improved and vital signs had remained stable. Patient was cleared to leave per Dr. More
2857867 0.5 F NC 09/10/2025 DTAPHEPBIP
FLU3
HIBV
RSV
RV5
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
PFIZER\WYETH
MERCK & CO. INC.
 b532g
7f299
y020468
kc7884
2139673
Inappropriate schedule of product administration, No adverse event, Product admi... Inappropriate schedule of product administration, No adverse event, Product administered to patient of inappropriate age; Inappropriate schedule of product administration, No adverse event, Product administered to patient of inappropriate age; Inappropriate schedule of product administration, No adverse event, Product administered to patient of inappropriate age; Inappropriate schedule of product administration, No adverse event, Product administered to patient of inappropriate age; Inappropriate schedule of product administration, No adverse event, Product administered to patient of inappropriate age More
Abrysvo given to 6-month-old. Pedvax HIB given off schedule. No known harm to patient at this time. Abrysvo given to 6-month-old. Pedvax HIB given off schedule. No known harm to patient at this time.
2857868 18 M MD 09/10/2025 COVID19
 PFIZER\BIONTECH
Chest pain, Dyspnoea, Influenza like illness, Nasopharyngitis, Pericarditis Chest pain, Dyspnoea, Influenza like illness, Nasopharyngitis, Pericarditis
The next day there were flu-like symptoms of a head cold, and then chest pain as well as shortness o... The next day there were flu-like symptoms of a head cold, and then chest pain as well as shortness of breath associated with pericarditis, which was diagnosed by a cardiologist to be pericarditis. More
2857869 0.67 F MI 09/10/2025 RV5
 MERCK & CO. INC.
 2124039
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
No adverse events noted. Vaccine given one day over recommended age No adverse events noted. Vaccine given one day over recommended age
2857870 69 M NY 09/10/2025 PNC21
 MERCK & CO. INC.
 ZOO3579
Rash pruritic, Skin warm Rash pruritic, Skin warm
4 to 6 inches in diameter, non raised rash. warm to the touch and itchy 4 to 6 inches in diameter, non raised rash. warm to the touch and itchy
2857871 54 M AZ 09/10/2025 COVID19
 PFIZER\BIONTECH
Poikilocytosis, Thalassaemia Poikilocytosis, Thalassaemia
Incurred blood disorder - Thalassemia and Poikilocytosis Incurred blood disorder - Thalassemia and Poikilocytosis
2857872 4 F SC 09/10/2025 DTAP
 SANOFI PASTEUR
 3CA20C1
Injection site cellulitis, Injection site erythema, Injection site swelling Injection site cellulitis, Injection site erythema, Injection site swelling
Patient with erythema, swelling, and redness to left upper thigh at injection site. Patient came in ... Patient with erythema, swelling, and redness to left upper thigh at injection site. Patient came in office 9/10/25 to have site evaluated. Diagnosed with cellulitis- started on Cephalexin for treatment. More
2857873 43 F ME 09/10/2025 COVID19
 MODERNA
 003c21a
Dry eye, Immediate post-injection reaction, Photophobia, Rheumatoid arthritis, S... Dry eye, Immediate post-injection reaction, Photophobia, Rheumatoid arthritis, Sicca syndrome More
Felt like I was becoming extremely sensitive to light immediately after injection but brushed it off... Felt like I was becoming extremely sensitive to light immediately after injection but brushed it off but over the course of a week could not even be outside with the light felt like I was going blind, also felt like the lubrication was being sucked out of my body. Now diagnosed sicca syndrome ans Keratosis sicca plus Rheumatoid Arthritis but suspect the Rheumatoid is related to almost dying from Pertussis vaccine when I was little. More
โœ“
2857874 4 F MI 09/10/2025 COVID19
 MODERNA
 3046979
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
none none
2857875 0.17 F MI 09/10/2025 DTAPHEPBIP
 GLAXOSMITHKLINE BIOLOGICALS
 39KS9
Expired product administered Expired product administered
expired by 3 days expired by 3 days
2857876 75 M CA 09/10/2025 COVID19
FLU3
 MODERNA
SANOFI PASTEUR
 3052296
U8847BA
Fatigue, Injection site pain, Pyrexia; Fatigue, Injection site pain, Pyrexia Fatigue, Injection site pain, Pyrexia; Fatigue, Injection site pain, Pyrexia
Fever, fatigue, injection site soreness Fever, fatigue, injection site soreness
2857877 12 F MA 09/10/2025 HEPA
MNQ
 GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR
 3255P
U8574AA
Immediate post-injection reaction, Syncope; Immediate post-injection reaction, S... Immediate post-injection reaction, Syncope; Immediate post-injection reaction, Syncope More
Vasovagal syncope occurred immediately after vaccine administration Vasovagal syncope occurred immediately after vaccine administration
2857878 85 F IN 09/10/2025 FLU3
 SANOFI PASTEUR
 UJ253AB
Cutaneous vasculitis Cutaneous vasculitis
Bilateral lower leg cutaneous vasculitis developed 1 week after influenza vaccine. In retrospect, sh... Bilateral lower leg cutaneous vasculitis developed 1 week after influenza vaccine. In retrospect, she has a similar left lower leg rash approximately one week after her influenza vaccine last year. More
2857879 62 M FL 09/10/2025 FLU3
RSV
TDAP
 SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 u8823aa
bg5j4
kr75k
Extra dose administered; Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered; Extra dose administered
pt received arexvy when they had already gotten the vaccine in december 2020 pt received arexvy when they had already gotten the vaccine in december 2020
2857880 78 M FL 09/10/2025 FLU3
PNC21
 SANOFI PASTEUR
MERCK & CO. INC.
 u8855ca
z006889
Rash; Rash Rash; Rash
severe rash- no treatment mentioned- 48 hours course severe rash- no treatment mentioned- 48 hours course
2857882 48 M NY 09/10/2025 COVID19
 PFIZER\BIONTECH
 EW0170
Cerebrovascular accident, Uveitis Cerebrovascular accident, Uveitis
Had uveitis symptoms a couple days after the 2nd Pfizer shot. Never had any eye problems in the past... Had uveitis symptoms a couple days after the 2nd Pfizer shot. Never had any eye problems in the past. The pain was so severe that I had to go to ER in the middle of the night. Eventually I booked an appointment to see an eye doctor who administered eye drops and the symptoms were stopped. However, a couple months later the same problem recurred. I went to a different doctor and finally cured it. The doctor mentioned it may be related to some autoimmune genes. Worse thing happened a few months later after the 2nd bout of uveitis. On June 22, 2022, I had a stroke. More
โœ“ โœ“ โœ“
2857883 66 F AL 09/10/2025 COVID19
 PFIZER\BIONTECH
 EL9264
Retinal detachment, Visual impairment, Vitrectomy, Vitreous haemorrhage Retinal detachment, Visual impairment, Vitrectomy, Vitreous haemorrhage
Pt experienced vitreous hemorrhage and retinal detachment in left eye; pt had to undergo vitrectomy ... Pt experienced vitreous hemorrhage and retinal detachment in left eye; pt had to undergo vitrectomy and to repair damage to retina (performed at Outpatient Surgery); pt reports vision was restored to baseline acuity with no significant complications More
2857884 72 F CA 09/10/2025 COVID19
FLU3
 MODERNA
SANOFI PASTEUR
 3052296
U8847BA
Cough, Headache, Injection site pain, Pyrexia, Rhinorrhoea; Cough, Headache, Inj... Cough, Headache, Injection site pain, Pyrexia, Rhinorrhoea; Cough, Headache, Injection site pain, Pyrexia, Rhinorrhoea More
Fever, runny nose, headache, cough, sore injection site Fever, runny nose, headache, cough, sore injection site
2857885 76 F NE 09/10/2025 COVID19
 MODERNA
 3052583
Injection site rash, Injection site warmth, Rash erythematous, Rash pruritic Injection site rash, Injection site warmth, Rash erythematous, Rash pruritic
Red almost rash like. Could be a bruise. not raised. at first warm to the touch, no longer warm 3 da... Red almost rash like. Could be a bruise. not raised. at first warm to the touch, no longer warm 3 days later. Rash is spreading. Covers arm from injection site to elbow and medial Biocept area. Rash has an irregular boarder. starts light from injection site and gets darker towards the elbow. Rash is itchy. More
2857886 67 M NJ 09/10/2025 FLU3
FLU3
FLU3
 SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
 U8847CA
U8847CA
U8847CA
Atrial fibrillation, Balance disorder, Chills, Condition aggravated, Dizziness; ... Atrial fibrillation, Balance disorder, Chills, Condition aggravated, Dizziness; Dyspnoea, Heart rate increased, Influenza, Injection site pain, Oxygen saturation decreased; Presyncope, Sleep disorder More
pt had severe AFIB (pulse was 114 and normal pulse is around 50-55) later the same day of receiving ... pt had severe AFIB (pulse was 114 and normal pulse is around 50-55) later the same day of receiving the vaccine. He had soreness at the injection site along with the dizziness, became light headed and had shortness of breath. He called his PCP. He was told to take flecainide 100mg and metoprolol 25mg. The next morning he took these same meds because he was still in AFIB. He also had flu symptoms at this time. He almost passed out and lost consciousness. He called his doctor again. He was told to stop taking the meds but to rest and keep an eye on his pulse. In the middle of the night he woke up with uncontrollable shivering like he was having a seizure. His pulse rate was 35 and pulse ox was 70%. He drank a lot of water, had Pedialyte and Gatorade. A little later the pulse rate was 42 and pulse was 90%. He was comfortable that he was getting better and the shivering had stopped so he took Tylenol and went to bed. He called his doctor again in the morning and was told to go to the ER if he had another episode like that. Over the weekend his pulse and pulse ox was lower than normal. He continued to take Tylenol for the flu like symptoms. He still feels a little bit out of balance but is better. He was told to stay in touch with the doctor and keep his follow up appt. More
โœ“
2857887 45 F DE 09/10/2025 PNC21
 MERCK & CO. INC.
 Y01957
Injected limb mobility decreased, Injection site pain, Sleep disorder Injected limb mobility decreased, Injection site pain, Sleep disorder
Severe arm pain at injection site, limiting movement Pain intensity described as unusually severe c... Severe arm pain at injection site, limiting movement Pain intensity described as unusually severe compared to prior muscular vaccine injections Pain persistent through the night, interfering with sleep Concern about prolonged duration of symptoms - Patient alternating with taking ibuprofen and tylenol. More
2857888 56 F MS 09/10/2025 FLU3
PNC21
 SANOFI PASTEUR
MERCK & CO. INC.
 u8823ca
z006889
Rash, Rash erythematous; Rash, Rash erythematous Rash, Rash erythematous; Rash, Rash erythematous
Large red rash on shoulder, warm to the touch. Recommended cold and warm compress. Md is sending i... Large red rash on shoulder, warm to the touch. Recommended cold and warm compress. Md is sending in a prescription. More
2857889 17 F KS 09/10/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 K7JY3
Mass, Pain, Shoulder injury related to vaccine administration Mass, Pain, Shoulder injury related to vaccine administration
Severe pain and lump that has continued since receiving injection. Has seen ortho doctor on 8/26/25 ... Severe pain and lump that has continued since receiving injection. Has seen ortho doctor on 8/26/25 that is calling this a SIRVA. Working with physical therapy More
๐Ÿ“‹ Privacy Policy & Data Disclaimer